A5091706003- Cardiac pacing and defibrillation studies
- Diabetes Treatment and Management
- Cardiovascular Effects of Exercise
- Infective Endocarditis Diagnosis and Management
- Medical Device Sterilization and Disinfection
- Cardiac Structural Anomalies and Repair
- Cardiac tumors and thrombi
- Traumatic Brain Injury and Neurovascular Disturbances
- Cardiac Arrest and Resuscitation
- Pancreatic function and diabetes
- Lymphoma Diagnosis and Treatment
- Folate and B Vitamins Research
- Cardiac Arrhythmias and Treatments
- Non-Invasive Vital Sign Monitoring
- Coronary Artery Anomalies
- Cardiac electrophysiology and arrhythmias
- Diabetes Management and Research
- Hemoglobinopathies and Related Disorders
- Pericarditis and Cardiac Tamponade
- Poisoning and overdose treatments
- Mechanical Circulatory Support Devices
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
University of Oxford
2023
Allegheny General Hospital
2017-2019
Allegheny Health Network
2019
Western Pennsylvania Hospital
2019
University of Pittsburgh Medical Center
2015
University of Pittsburgh
2015
University Health Network
2014
The EMPA-KIDNEY trial showed that empagliflozin reduced the risk of primary composite outcome kidney disease progression or cardiovascular death in patients with chronic mainly through slowing progression. We aimed to assess how effects might differ by across its broad population.
Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk cardiovascular morbidity mortality in a wide range patients. However, their effects on some patients with are unclear because few clinical outcomes occurred among such completed trials. In particular, guidelines stratify level recommendation about who should be treated SGLT2 based diabetes status albuminuria. We aimed to assess empagliflozin both overall specific types participants...
Primary cardiac lymphoma accounts for <2% of all primary tumours. It is uncommon in immunocompetent patients, often fatal and diagnosed at autopsy. Tumour usually involves the right heart chambers pericardium. With advances imaging, early diagnosis possible treatment including chemotherapy surgery affords good prognosis.We present a 50-year-old woman with abdominal pain fevers 5 days. Computed tomography abdomen showed splenic renal infarcts but no mass or vegetation was noted on...
Introduction: Sickle cell disease (SCD) has been shown in multiple studies worldwide to be associated with considerable morbidity and mortality, including a higher risk for acute myocardial infarction (AMI). However, the effect of SCD on outcome patients remains unclear. We sought investigate in-hospital mortality presenting ST elevation (STEMI) compared general population. Hypothesis: Short term STEMI is when Methods: The National Inpatient Sample (NIS), part Healthcare Cost Utilization...
Background: Endothelial dysfunction (ED) may occur after cardiac arrest (CA) both due to the underlying patient comorbidities which result in CA and global ischemia-reperfusion results. The prevalence of ED is poorly characterized as any association with outcomes. Hypothesis: will be more common asphyxial arrests, prolonged CPR times subjects multiple coronary artery risk factors. associate worsened Methods: Prospective, observational study 23 return spontaneous circulation (ROSC) expected...